Staphylococcal infections in children, California, USA, 1985-2009

Emerg Infect Dis. 2013 Jan;19(1):10-20; quiz 185. doi: 10.3201/eid1901.111740.

Abstract

We conducted a retrospective, observational, population-based study to investigate the effect of staphylococcal infections on the hospitalization of children in California during 1985-2009. Hospitalized children with staphylococcal infections were identified through the California Office of Statewide Health Planning and Development discharge database. Infections were categorized as community onset, community onset health care-associated, or hospital onset. Infection incidence was calculated relative to all children and to those hospitalized in acute-care facilities. A total of 140,265 records were analyzed. Overall incidence increased from 49/100,000 population in 1985 to a peak of 83/100,000 in 2006 and dropped to 73/100,000 in 2009. Staphylococcal infections were associated with longer hospital stays and higher risk for death relative to all-cause hospitalizations of children. The number of methicillin-resistant Staphylococcus aureus infections increased, and the number of methicillin-susceptible S. aureus infections remained unchanged. Children <3 years of age, Blacks, and those without private insurance were at higher risk for hospitalization.

MeSH terms

  • Adolescent
  • California / epidemiology
  • Child
  • Child, Preschool
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / mortality
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Cross Infection / mortality
  • Databases, Factual
  • Epidemiological Monitoring
  • Female
  • Hospitalization
  • Humans
  • Incidence
  • Infant
  • Length of Stay
  • Male
  • Methicillin / pharmacology
  • Methicillin / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus / physiology*
  • Racial Groups
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / mortality
  • Survival Analysis

Substances

  • Methicillin